Showing results (91-100 of 134) with videos related to
Sort By:
Pageof 14
Computers in Biology and Medicine|April 17, 2014
Breast cancer detection from MR images through an auto-probing discrete Fourier transform systemK S Sim, F K Chia, M E Nia, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeMaggie C U Cheang, David Voduc, Chris Bajdik, et al.The Malaysian Journal of Pathology|December 29, 2016
Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case reportY L Tang, W K Chia, E C S W Yap, et al.Clinical Immunology (Orlando, Fla.)|April 7, 2009
G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivoHan C Toh, Li Sun, Yatanar Soe, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 2026
Broad-Spectrum Antibiotics are Associated with worse Survival After Radical Treatment for Glioblastoma Multiforme: A Multicentre StudyS Main, A Swampillai, J Lavrador, et al.Hepatobiliary Surgery and Nutrition|February 24, 2016
Does diabetes mellitus affect presentation, stage and survival in operable pancreatic cancer?Clement L K Chia, Anthea Y S Lee, Vishal G Shelat, et al.Clinical Breast Cancer|October 25, 2021
Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility StudyNathalie LeVasseur, Julia Sun, David Fenton, et al.Clinical Breast Cancer|July 25, 2008
Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancerSimon J Crabb, Maggie C U Cheang, Samuel Leung, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinomaS K Chia, C C Wykoff, P H Watson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2017
Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2+-Advanced Solid Tumors, with an Expansion Cohort in HER2+ Metastatic Breast Cancer (MBC)Stacy L Moulder, Virginia F Borges, Tara Baetz, et al.Pageof 14